Literature DB >> 3002822

Role of Ca2+ and Ca2+-activated protease in myoblast fusion.

J E Schollmeyer.   

Abstract

In this report, we have examined the effects of a calcium chelator, EGTA, and a calcium ionophore, A23187, on fusion of a cloned muscle cell line, L6. Our results confirm that EGTA essentially blocks all myoblast fusion because the lateral alignment of presumptive myoblasts cannot occur in the absence of extracellular calcium. A23187, however, promotes the precocious fusion of myoblasts, apparently by facilitating Ca2+ transport into myoblasts. We have also demonstrated that a Ca2+-activated protease, CAF (mM), appears to relocate in response to the Ca2+ flux, changing from a random, dispersed distribution in proliferative myoblasts to a predominantly peripheral distribution in prefusion myoblasts. Coincident with the mM CAF relocation is an altered distribution of a surface glycoprotein, fibronectin. Extracellular fibronectin is seen in abundance in proliferating myoblasts, but is essentially absent from the surface of fusing myoblasts. We suggest that mM CAF when activated by Ca2+ influx may act to promote the release of fibronectin from the myoblast cell surface, thus providing a mechanism by which the membrane of the fusing myoblast may be rearranged to accommodate fusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3002822     DOI: 10.1016/0014-4827(86)90346-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability.

Authors:  S Barnoy; L Supino-Rosin; N S Kosower
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line.

Authors:  Elise Dargelos; Stephane Dedieu; Catherine Moyen; Sylvie Poussard; Philippe Veschambre; Jean-Jacques Brustis; Patrick Cottin
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

4.  Constant expression of mouse calpastatin isoforms during differentiation in myoblast cell line, C2C12.

Authors:  K Hitomi; M Murase; T Kawamura; M Maki
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

5.  Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse.

Authors:  James G Tidball; Melissa J Spencer
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 6.  Exercise-induced muscle injury: a calpain hypothesis.

Authors:  A N Belcastro; L D Shewchuk; D A Raj
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

7.  A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes.

Authors:  B Belles; J Hescheler; W Trautwein; K Blomgren; J O Karlsson
Journal:  Pflugers Arch       Date:  1988-10       Impact factor: 3.657

8.  Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies.

Authors:  J A Samis; G Zboril; J S Elce
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

9.  The effects of eccentric contraction on myofibrillar proteins in rat skeletal muscle.

Authors:  Keita Kanzaki; Mai Kuratani; Takaaki Mishima; Satoshi Matsunaga; Noriyuki Yanaka; Sachio Usui; Masanobu Wada
Journal:  Eur J Appl Physiol       Date:  2010-07-21       Impact factor: 3.078

10.  Immunological detection of m- and µ-calpains in the skeletal muscle of Marchigiana cattle.

Authors:  E Varricchio; M G Russolillo; L Maruccio; S Velotto; G Campanile; M Paolucci; F Russo
Journal:  Eur J Histochem       Date:  2013-01-14       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.